Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation

Tae Suk Kim, Dai Jin Kim, Heejin Lee, Yong Ku Kim

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Recent animal studies have suggested an association between nicotine and alterations in brain-derived neurotrophic factor (BDNF) expression levels. However, the role of BDNF in humans with nicotine dependence has not yet been investigated. In this study, we explored the differences in the plasma BDNF levels of chronic smokers and healthy nonsmokers, and we investigated the changes in plasma BDNF levels in chronic smokers following unaided smoking cessation. Forty voluntary participants (20 smokers and 20 nonsmokers) were enrolled in this study. We measured the plasma BDNF levels at baseline (both groups) and at the end of the two-month study period (smoker group only) using an enzyme-linked immunosorbent assay. A total of 12 smokers (60.0%) completed the two-month study. ANCOVA with age and body mass index as covariates showed that the baseline plasma BDNF levels in smokers were significantly lower than those in nonsmokers (F = 4.626, p = 0.038). The plasma BDNF levels in the smokers significantly increased from baseline after the two-month smoking cessation period (Z = -3.059, p = 0.002). These findings suggest that BDNF may play a role in the pathophysiology of smoking behavior.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalNeuroscience Letters
Volume423
Issue number1
DOIs
Publication statusPublished - 2007 Aug 9

Fingerprint

Brain-Derived Neurotrophic Factor
Smoking Cessation
Tobacco Use Disorder
Nicotine
Body Mass Index
Smoking
Enzyme-Linked Immunosorbent Assay

Keywords

  • Addiction
  • BDNF
  • Nicotine
  • Smoking
  • Smoking cessation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. / Kim, Tae Suk; Kim, Dai Jin; Lee, Heejin; Kim, Yong Ku.

In: Neuroscience Letters, Vol. 423, No. 1, 09.08.2007, p. 53-57.

Research output: Contribution to journalArticle

@article{00563ae6035f4c23afeaa0664b59782d,
title = "Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation",
abstract = "Recent animal studies have suggested an association between nicotine and alterations in brain-derived neurotrophic factor (BDNF) expression levels. However, the role of BDNF in humans with nicotine dependence has not yet been investigated. In this study, we explored the differences in the plasma BDNF levels of chronic smokers and healthy nonsmokers, and we investigated the changes in plasma BDNF levels in chronic smokers following unaided smoking cessation. Forty voluntary participants (20 smokers and 20 nonsmokers) were enrolled in this study. We measured the plasma BDNF levels at baseline (both groups) and at the end of the two-month study period (smoker group only) using an enzyme-linked immunosorbent assay. A total of 12 smokers (60.0{\%}) completed the two-month study. ANCOVA with age and body mass index as covariates showed that the baseline plasma BDNF levels in smokers were significantly lower than those in nonsmokers (F = 4.626, p = 0.038). The plasma BDNF levels in the smokers significantly increased from baseline after the two-month smoking cessation period (Z = -3.059, p = 0.002). These findings suggest that BDNF may play a role in the pathophysiology of smoking behavior.",
keywords = "Addiction, BDNF, Nicotine, Smoking, Smoking cessation",
author = "Kim, {Tae Suk} and Kim, {Dai Jin} and Heejin Lee and Kim, {Yong Ku}",
year = "2007",
month = "8",
day = "9",
doi = "10.1016/j.neulet.2007.05.064",
language = "English",
volume = "423",
pages = "53--57",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation

AU - Kim, Tae Suk

AU - Kim, Dai Jin

AU - Lee, Heejin

AU - Kim, Yong Ku

PY - 2007/8/9

Y1 - 2007/8/9

N2 - Recent animal studies have suggested an association between nicotine and alterations in brain-derived neurotrophic factor (BDNF) expression levels. However, the role of BDNF in humans with nicotine dependence has not yet been investigated. In this study, we explored the differences in the plasma BDNF levels of chronic smokers and healthy nonsmokers, and we investigated the changes in plasma BDNF levels in chronic smokers following unaided smoking cessation. Forty voluntary participants (20 smokers and 20 nonsmokers) were enrolled in this study. We measured the plasma BDNF levels at baseline (both groups) and at the end of the two-month study period (smoker group only) using an enzyme-linked immunosorbent assay. A total of 12 smokers (60.0%) completed the two-month study. ANCOVA with age and body mass index as covariates showed that the baseline plasma BDNF levels in smokers were significantly lower than those in nonsmokers (F = 4.626, p = 0.038). The plasma BDNF levels in the smokers significantly increased from baseline after the two-month smoking cessation period (Z = -3.059, p = 0.002). These findings suggest that BDNF may play a role in the pathophysiology of smoking behavior.

AB - Recent animal studies have suggested an association between nicotine and alterations in brain-derived neurotrophic factor (BDNF) expression levels. However, the role of BDNF in humans with nicotine dependence has not yet been investigated. In this study, we explored the differences in the plasma BDNF levels of chronic smokers and healthy nonsmokers, and we investigated the changes in plasma BDNF levels in chronic smokers following unaided smoking cessation. Forty voluntary participants (20 smokers and 20 nonsmokers) were enrolled in this study. We measured the plasma BDNF levels at baseline (both groups) and at the end of the two-month study period (smoker group only) using an enzyme-linked immunosorbent assay. A total of 12 smokers (60.0%) completed the two-month study. ANCOVA with age and body mass index as covariates showed that the baseline plasma BDNF levels in smokers were significantly lower than those in nonsmokers (F = 4.626, p = 0.038). The plasma BDNF levels in the smokers significantly increased from baseline after the two-month smoking cessation period (Z = -3.059, p = 0.002). These findings suggest that BDNF may play a role in the pathophysiology of smoking behavior.

KW - Addiction

KW - BDNF

KW - Nicotine

KW - Smoking

KW - Smoking cessation

UR - http://www.scopus.com/inward/record.url?scp=34547434714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547434714&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2007.05.064

DO - 10.1016/j.neulet.2007.05.064

M3 - Article

C2 - 17662528

AN - SCOPUS:34547434714

VL - 423

SP - 53

EP - 57

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -